UnitedHealth Group reports mixed second quarter earnings; stock down in premarket trading

UnitedHealth Group (UNH) reported mixed Q2 results, beating revenue expectations with $111.6 billion but missing on adjusted EPS at $4.08, leading to a more than 5% stock decline. The underperformance was primarily driven by a record medical expense ratio of 89.4%, reflecting higher-than-expected utilization of care, particularly among seniors, a trend that continues to impact the broader health insurance industry. Amid shrinking margins, UNH updated its full-year guidance and announced plans to exit several Medicare Advantage markets, affecting 600,000 patients, with anticipated premium increases next year due to ongoing cost pressures and expiring ACA subsidies.

Analysis

UnitedHealth Group's (UNH) second-quarter results reveal a significant margin contraction despite a slight top-line beat, triggering a more than 5% decline in its stock. The company reported revenues of $111.6 billion, marginally above the $111.53 billion consensus, but its adjusted EPS of $4.08 fell substantially short of the $4.59 expectation. The primary driver of the earnings miss was a historically high medical expense ratio (MER) of 89.4%, a sharp increase from 84.8% in the prior quarter and well above the industry's target range of 80-85%. This record MER, fueled by higher-than-anticipated healthcare utilization among seniors, confirms a pervasive and challenging cost trend impacting the entire health insurance sector, with peers like Centene (CNC) and Elevance (ELV) facing similar pressures. The profitability impact is stark, with margins shrinking to 3.1% from 4.3% a year ago. In response, UNH has reinstated full-year guidance with adjusted EPS of at least $16, but is also taking defensive measures, including exiting certain Medicare Advantage markets affecting 600,000 patients and signaling premium hikes for next year. These actions, coupled with anticipated headwinds from expiring ACA subsidies, underscore a difficult operating environment and a strategic pivot towards margin preservation over member growth.

Key Decisions for Investors

• Investors should closely monitor the medical expense ratio trend in the coming quarters, as management's inability to accurately forecast utilization presents a primary risk to earnings stability for UNH and its peers.
• Evaluate the strategic decision to exit specific markets and raise premiums; while this may stabilize margins, it could lead to market share erosion and attract negative regulatory attention.
• Given the updated guidance and persistent industry-wide cost pressures, the post-earnings stock decline may not represent an immediate buying opportunity until there is clearer evidence of cost trend stabilization or successful repricing actions in 2025.